Nantahala Capital Management LLC 13D and 13G filings for :
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:51 pm Sale | 2023-12-31 | 13G | Aptose Biosciences Inc. APTO | Nantahala Capital Management LLC | 120,132 1.500% | -5,932,735 (-98.02%) | Filing |
| 2023-02-14 4:56 pm Sale | 2022-12-31 | 13G | Aptose Biosciences Inc. APTO | Nantahala Capital Management LLC | 403,524 6.600% | -103,455 (-20.41%) | Filing |
| 2022-02-14 08:03 am Purchase | 2021-12-31 | 13G | Aptose Biosciences Inc. APTO | Nantahala Capital Management LLC | 506,980 8.500% | 22,135 (+4.57%) | Filing |
| 2021-02-12 3:25 pm Purchase | 2020-12-31 | 13G | Aptose Biosciences Inc. APTO | Nantahala Capital Management LLC | 484,845 8.200% | 81,256 (+20.13%) | Filing |
| 2020-02-14 12:18 pm Purchase | 2019-12-31 | 13G | Aptose Biosciences Inc. APTO | Nantahala Capital Management LLC | 403,589 8.000% | 403,589 (New Position) | Filing |